2004 (12) TMI 92 - SC - Central Excise

Show-cause notices quashed for misapplying legal tests; appeals dismissed with no costs order; department may reassess products

SC held the show cause notices were unsustainable because they proceeded on a misapprehension of the applicable tests; consequently the appeals were ... Classification of goods as pharmaceutical product or cosmetic - popular/common parlance test for tariff classification - burden of proof on the revenue to establish tariff classification - reliance on sales channels and prescription practice as determinative tests - reclassification requires change in nature, use or fresh interpretationClassification of goods as pharmaceutical product or cosmetic - popular/common parlance test for tariff classification - burden of proof on the revenue to establish tariff classification - reliance on sales channels and prescription practice as determinative tests - Validity of show cause notices seeking to reclassify the assessee's turmeric skin cream and vajradanti toothpaste/tooth powder from Chapter 30 to Chapter 33 - HELD THAT: - The Court held that the Department's show cause notices were founded on a misapprehension of the tests laid down in Shree Baidyanath's case and could not sustain reclassification merely because a judicial decision exists. The proper test for classification is the meaning attached by consumers in common parlance rather than purely scientific or technical labels; the burden lies on the revenue to prove that a product is understood as falling under a particular tariff heading. The Court rejected the Department's reliance on two simplistic criteria - daily use and sale without prescription or availability in general stores - as determinative of pharmaceutical classification. Prior precedents were examined to show that sale channels or absence of prescription do not automatically convert a medicament into a cosmetic, and that classification requires proof of how the product is popularly understood or, where relevant, affirmative indications such as packaging and literature showing use as a cosmetic. [Paras 4, 5, 7, 8, 9]The show cause notices, having proceeded on the stated misapprehension of the tests, cannot be sustained and the appeals are dismissed.Reclassification requires change in nature, use or fresh interpretation - Permissibility of the Department to undertake further tests or steps for proper classification - HELD THAT: - While the Court dismissed the appeals against the impugned show cause notices, it observed that the mere existence of earlier judicial decisions does not by itself justify changing classification absent a change in the product's nature, its use, or a fresh interpretation. The Court therefore left open the procedural avenue for the Department, if otherwise entitled, to conduct such tests or take steps to determine the correct tariff classification of the products. [Paras 4, 9]It is open to the Department to undertake such tests or steps as may be appropriate to classify the products under the correct tariff heading.Final Conclusion: The appeals are dismissed; the Department's show cause notices based on the misinterpreted tests cannot be sustained, but the Department remains at liberty to conduct appropriate tests or proceedings, if entitled, to determine correct classification. Issues: Classification of products under Central Excise Tariff Act - Chapter 30 vs. Chapter 33In this judgment, the Supreme Court addressed the issue of classifying products under the Central Excise Tariff Act, specifically whether certain products should be classified under Chapter 30 (pharmaceutical products) or Chapter 33 (perfumery cosmetics and toilet preparations). The products in question were turmeric skin cream and vajradanti toothpaste and tooth powder for the period between October 1996 and June 1997.The respondent's products were initially classified as a patent or proprietary medicine under Tariff Heading 14-E and later under Chapter 30 as pharmaceutical products. The appellant contended that the products should be classified under Chapter 33 as cosmetics, citing a previous court decision and specific tests for classification.The court emphasized that a mere court decision is not sufficient to change the classification without a change in the nature or use of the product, or a fresh interpretation of the tariff heading. The decision in Shree Baidyanath's case was discussed, where the Tribunal considered the product's common parlance description as a toilet preparation, not a medicinal one. The court upheld the Tribunal's approach of considering the popular meaning of terms used in the Excise Act.The court also noted that the Tribunal's rejection of the claim that a medicine is prescribed by a medical practitioner and used for a limited time unless for specific diseases like diabetes. The court affirmed this reasoning but did not establish it as the sole test for classification. Another case involving the classification of a medicated shampoo as a medicine was referenced to show the criteria for a product to be considered a cosmetic.Additionally, the court mentioned Chapter Note 1(d) of Chapter 30, the impact of which may need to be considered in a suitable case. It highlighted a previous case where the Department's approach of classifying a product as a cosmetic solely based on not being sold by chemists or under doctors' prescriptions was disapproved. The burden of proof for classification lies with the revenue to prove how consumers understand the product.Ultimately, the court dismissed the appeals due to the show cause notices being issued based on a misinterpretation of the tests laid down in a previous case. The Department was given the opportunity to conduct appropriate tests for classifying the products under the correct tariff heading.